Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. People
  4. /
  5. Kent A. Conforti
FDA Person
•FDA

Kent A. Conforti

View detailed information about Kent A. Conforti, including compliance records, violations, and related data.

Sign in to open in Dashboard
Person Profile

FDA investigator. Took part in 110 inspections of 102 companies, 2016–2026.

Inspections (110)
DateCompanyClassificationProject areaInspection
September 21, 2026Biogen, Inc.Not classified#1340116
August 20, 2026Alexis M. Cahalane, M.D.Not classified#1334006
July 31, 2026Vertex Pharmaceuticals IncorporatedNot classified#1333028
July 10, 2026Praxis Precision Medicines, Inc.Not classified#1332596
June 24, 2026Jeremy Schmahmann, M.D.Not classified#1324468
May 29, 2026Biomedical Research Models, Inc. d/b/a BiomereNot classifiedHuman Cellular, Tissue, and Gene Therapies#1319406
April 30, 2026Giuseppe Plazzi, M.D.Not classified#1317562
April 10, 2026Takeda Pharmaceuticals USANot classified#1313228
March 19, 2026Peter R. Movilla, MDNot classifiedProduct Evaluation: Medical Devices#1308722
March 6, 2026Marek SmilowskiNAIBioresearch Monitoring#1309212
February 13, 2026Moderna TX Clinical Biomarker LaboratoryNot classified#1308088
January 14, 2026Nuvalent, Inc.Not classified#1300422
December 19, 2025Daniel J. DeAngelo, MDNot classified#1297612
November 17, 2025Health Policy Associates, IncNot classified#1292882
October 21, 2025Filipa Lynce, M.D.VAIBioresearch Monitoring: Human Drugs#1287944
October 21, 2025Filipa Lynce, M.D.VAIBioresearch Monitoring#1287944
September 26, 2025University of Vermont & State Agricultural College IRBNot classified#1284600
September 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.VAIBioresearch Monitoring: Human Drugs#1281125
August 8, 2025Amer M. Zeidan, M.D.VAIBioresearch Monitoring: Human Drugs#1278299
July 18, 2025Amir T. Fathi, M.D.NAIBioresearch Monitoring#1277066
See all 110 inspections in the dashboard
Documents (45)
  • EIR · Servier Pharmaceuticals, LLC. · March 24, 2022
  • EIR · Charles Stephen Foster, M.D. · May 21, 2018
  • EIR · Karen D. Wright, M.D. · October 18, 2021
  • 483 · Filipa Lynce, M.D. · October 21, 2025
  • 483 · Pfizer Inc. · September 22, 2017
  • 483 · Mass General Brigham Inc. IRB · May 23, 2017
  • 483 · Inci B. Yildirim, M.D. · April 15, 2022
  • EIR · Sarepta Therapeutics, Inc. · April 12, 2018
  • EIR · Covis Pharma GmBH · October 22, 2018
  • 483 · Francine M. Foss · February 3, 2023
  • 483 · Aldeyra Therapeutics, Inc. · April 28, 2023
  • 483 · Alexion Pharmaceuticals, Inc. · November 7, 2024
  • 483 · Filipa Lynce, M.D. · October 21, 2025
  • 483 · Sait Ashina, M.D. · April 8, 2025
  • 483 · Amer M. Zeidan, M.D. · August 8, 2025
  • 483 · Bertrand P. Cole, D.O. · May 16, 2025
  • 483 · Labcorp Bedford LLC. · January 24, 2019
  • 483 · GE Healthcare Inc. - Life Sciences · March 8, 2024
  • 483 · Aditya Bardia, M.D. · February 8, 2021
  • 483 · Elizabeth I. Buchbinder, M.D. · October 3, 2022
  • 483 · Labcorp Bedford LLC. · September 14, 2021
  • 483 · Maria Alora Palli, M.D. · April 29, 2019
  • 483 · Maryellen Fitzgerald, M.D. · March 10, 2023
  • EIR · Blueprint Medicines Corporation · September 5, 2019
  • 483 · Andrew C. Siesennop, MD · August 4, 2023
  • 483 · Lumicell, Inc. · August 18, 2023
  • 483 · Boehringer Ingelheim Pharmaceuticals, Inc. · September 11, 2025
  • 483 · Pfizer, Inc. · June 28, 2017
  • EIR · ImmunoGen, Inc. · July 28, 2022
  • 483 · Jennifer L. Crombie, M.D. · November 17, 2023
  • EIR · Concord Biomedical Science and Emerging Technologies, Inc. · May 23, 2019
  • 483 · Concord Biomedical Science and Emerging Technologies, Inc. · May 23, 2019
  • EIR · bluebird bio, Inc. · May 6, 2022
  • 483 · Nezabravka Petrova Haytova · December 16, 2022
  • 483 · Caron Jacobson, Md · December 16, 2020
  • EIR · Pfizer Inc. · June 28, 2017
  • 483 · Purdue Pharma L.P. · March 29, 2019
  • 483 · Wayne G. Shreffler, M.D. · January 31, 2020
  • 483 · Resilience US, Inc. · October 10, 2008
  • 483 · Dr. A. Sharda · April 7, 2016
  • EIR · Pfizer Inc. · September 22, 2017
  • 483 · Kaleido Biosciences, Inc. · March 3, 2021
  • 483 · Douglas Terp · June 28, 2021
  • 483 · Peter R. Movilla, MD · March 19, 2026
  • 483 · Biomedical Research Models, Inc. d/b/a Biomere · May 29, 2026
Frequently inspected with (10)
Meredith L. Miller
5 shared
Michael P Anthony
3 shared
Agata E. Libera
2 shared
John L. Zaccone

Podcast Host

2 shared
Aisha P. Johnson
1 shared
Darin S. Wiegers
1 shared
Hugh M. McClure III
1 shared
Jennifer C. Adams

issuing_officer

1 shared
Kara A. Scheibner

issuing_officer

1 shared
Michelle S. Anantha
1 shared
Person Information

Name

Kent A. Conforti

Title

issuing_officer

Role

COMPANY REP

ID: 8d3d3e82-cd97-420e-8840-df92d6eeba09

Get More Insights

Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.